Gottlieb Highlights Commitment to Expanded Access to Trials

International Pharmaceutical Regulatory Monitor
A A
Commissioner Scott Gottlieb unveiled a redesigned FDA website on expanded access to clinical trials on Nov. 8 and said the agency is “deeply committed” to helping critically ill patients with no other treatment options to join trials.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00